Is CHNG undervalued or overvalued?
As of 2025-03-19, the Intrinsic Value of Change Healthcare Inc (CHNG) is 7.30 USD. This CHNG valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 27.49 USD, the upside of Change Healthcare Inc is -73.40%. This means that CHNG is overvalued by 73.40%.
The range of the Intrinsic Value is (2.37) - 219.47 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (2.37) - 219.47 | 7.30 | -73.4% |
| DCF (Growth 10y) | 0.67 - 272.65 | 12.65 | -54.0% |
| DCF (EBITDA 5y) | 13.16 - 34.17 | 18.75 | -31.8% |
| DCF (EBITDA 10y) | 12.58 - 41.65 | 20.99 | -23.7% |
| Fair Value | -1.17 - -1.17 | -1.17 | -104.26% |
| P/E | (12.75) - (13.22) | (12.74) | -146.3% |
| EV/EBITDA | 11.74 - 46.10 | 25.32 | -7.9% |
| EPV | 4.55 - 22.18 | 13.37 | -51.4% |
| DDM - Stable | (2.62) - (12.01) | (7.31) | -126.6% |
| DDM - Multi | 3.58 - 12.98 | 5.64 | -79.5% |
| Market Cap (mil) | 9,025.21 |
| Beta | 0.92 |
| Outstanding shares (mil) | 328.31 |
| Enterprise Value (mil) | 13,422.47 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.01% |
| Cost of Debt | 13.93% |
| WACC | 7.97% |